DICE Therapeutics Long Term Debt

DICE Therapeutics (DICE) currently reports a long-term debt of $11M as of June 2023. That compares with $13M in the prior-year period — down 12.2% year over year. Use the charts on this page to explore DICE Therapeutics's long-term debt history and peer comparisons.

DICE Therapeutics's long-term debt decreased from $13M to $11M — a 12.2% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DICE Therapeutics reported $11M in long-term debt as of June 2023. That compares with $13M in the prior-year period — down 12.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DICE Therapeutics, and consider following DICE for alerts when major investors trade the stock.

DICE Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DICE with unrelated industries.